Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.

Human immunology - 1 Nov 2014

Jiang Jingwei, Guo Weijian, Liang Xiaohua

Abstract excerpt

Myeloid-derived suppressor cells (MDSCs) comprise a group of heterogeneous and immature myeloid-derived cells. MDSCs accumulate in the blood, lymphoid organs, spleens and tumor tissues under different pathogenic conditions such as infection, trauma, hematosepsis, and especially oncogenesis. MDSCs can suppress both adaptive and innate immunities through multiple mechanisms. However, most of our knowledge of MDSCs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antineoplastic Agents
Share to Cell Lineage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Management

Share to Immunophenotyping

Share to Myeloid Cells

Share to Neoplasm Proteins

Share to Neoplasms

Source

Identifiers

PMID: 25305034
DOI: 10.1016/j.humimm.2014.09.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.PMID 25305034Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Semantic proximity Read ↗

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Semantic proximity Read ↗

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.Semantic proximity Read ↗

Myeloid‐derived suppressor cell heterogeneity in human cancersSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDSSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.Semantic proximity Read ↗

Plasticity and biological diversity of myeloid derived suppressor cells.Semantic proximity Read ↗

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.